AOD 9604 is a synthetic hGH-derived peptide fragment with limited early-phase human trial data and no MHRA or EMA Marketing Authorisation
We show, using high-resolution cryo-EM, the binding of a benzene sulphonamide compound with a PV serotype 2 VLP, consistent with antiviral activity through over-stabilizing the interprotomer pocket, preventing the capsid rearrangements necessary for viral infection
The logic chain is sound, but the clinical endpoint data
There is no established human dose, no published human safety data, and no monograph.
Recent investigations have highlighted a significant correlation between NAFLD and MDD, suggesting that NAFLD might independently elevate the risks of anxiety and depression (273)
Their knowledge, compassion, and attention to detail are unmatched, and it is clear they genuinely know what they are doing